Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.

Archives of gynecology and obstetrics

Volumn 284, Issue 5, 2011, Pages 1295-1301

  Irez, Tulay ^a   Ocal, Pelin ^b   Guralp, Onur ^b   Cetin, Meral ^b   Aydogan, Begum ^b   Sahmay, Sezai ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FERTILITY PROMOTING AGENT; GONADOTROPIN; INHIBIN; INHIBIN B; LEUPRORELIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD; BODY MASS; DRUG EFFECT; EMBRYO DEVELOPMENT; FEMALE; FEMALE INFERTILITY; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; OVARY FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ANTI-MULLERIAN HORMONE; BODY MASS INDEX; EMBRYONIC DEVELOPMENT; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; INHIBINS; LEUPROLIDE; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 85027943854     PISSN: None     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1979-6     Document Type: Article

References (0)